CRESTPOINT MANAGEMENT LTD

CRESTPOINT MANAGEMENT LTD specializes in advanced manufacturing and precision production services aligned with NAICS 339112, which encompasses medical equipment and supplies manufacturing. The company delivers end-to-end fabrication, assembly, and quality control solutions for regulated medical devices and diagnostic instrumentation, emphasizing compliance with FDA Quality System Regulation (QSR), ISO 13485 standards, and sterile processing protocols. Their technical expertise includes low-volume, high-complexity production runs, cleanroom assembly, biocompatible material handling, and validation documentation for Class II medical devices. Key differentiators lie in their focus on regulatory readiness, design-for-manufacturability consulting, and supply chain traceability systems tailored to FDA and ISO audit requirements. No agency award history is available to infer specific federal relationships or mission alignment. Consequently, there is insufficient data to identify recurring government clients or programmatic work patterns. The contractor’s primary industry focus is medical device manufacturing, with operational specialization in small-batch, high-precision production for diagnostic, surgical, and implantable devices. Their market positioning centers on serving OEMs and contract manufacturers requiring compliant, scalable production environments with rigorous documentation controls. The business does not appear to target broader defense or civilian federal systems but remains focused on the regulated healthcare product lifecycle. As a small business structured as a 2L entity, CRESTPOINT MANAGEMENT LTD operates from Saint Louis, Missouri, with a lean, specialized workforce focused on technical manufacturing execution. The company holds no active government certifications such as 8(a), HUBZone, or WOSB, and its market presence is defined by its niche expertise in medical device production rather than broad federal contracting reach. Its geographic footprint is localized, with operations centered on regional supply chains supporting medical device innovation.